This website has information about type 2 diabetes and how TENGLYN M and TENGLYN works to lower blood sugar.

Tenglyn

Location Our Location

Zydus Tower, Satellite Cross Roads, Ahmedabad.

Form Say No To Diabetes

Diabetes is fast gaining the status of a potential epidemic.

Recent Updates

364 patients continued in a 28-week open label extension during which they received teneligliptin 20 mg OD In initial 24 weeks, addition of teneligliptin reduced HbA1c by 0.63%. this response was maintained in 28 weeks extension with 20 mg teneligliptin. Treatment was well tolerated and the overall incidence of hypoglycemia during 52 weeks was 2.3% only.

The study concluded that Teneligliptin co-administered with metformin produced significant reductions in HbA1c in patients with T2DM without increasing the risk of hypoglycemia.

Link for Abstract/Full text: http://dx.doi.org/10.1080/14656566.2016.1190334

In Indian study, teneligliptin reduced HbA1c by 1.28% (Baseline HbA1c: 10.2%)

Link for Abstract/Full text: http://am.aace.com/sites/all/files/Late-Breaking-2016.pdf

A DPP-4 inhibitor for the treatment of type 2 diabetes

Link for Abstract/Full text: http://www.ncbi.nlm.nih.gov/pubmed/23671395